Bradykinesia in early Huntington's disease

被引:68
作者
Sánchez-Pernaute, R
Künig, G
Alba, AD
de Yébenes, JG
Vontobel, P
Leenders, KL
机构
[1] Fdn Jimenez Diaz, Dept Neurol, E-28040 Madrid, Spain
[2] Paul Scherrer Inst, PET Unit, Villigen, Switzerland
[3] Acad Ziekenhuis, Dept Neurol, Groningen, Netherlands
关键词
Huntington's disease; striatum; raclopride C11; bradykinesia; PET; D-2; receptor;
D O I
10.1212/WNL.54.1.119
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Hunting-ton's disease (HD) is generally considered a hyperkinetic disorder, although hypokinetic features are part of the motor syndrome. Moreover, the striatum is considered to play a key role in initiating and executing motor programs and achieving optimal scheduling in response generation. Controversial results regarding the association between clinical features and markers of progression of the disease might be the result of inadequate restriction of clinical signs to the choreatic syndrome. Objective: To determine the relationship of neurologic motor and cognitive indices in patients with HD with intrinsic neuronal loss in the striatum, as measured using raclopride C11 and PET. Patients and Methods: A cross-sectional study was performed on 11 patients with mild HD (stages 0-2). Motor (Unified Huntington's Disease Rating Scale [UHDRS], saccadic and tapping speed) and cognitive (verbal fluency, Trail Making Test, Stroop Test, Symbol Digit Modalities Test, Conditioned Associative Learning Test, and silhouette identification and object decision of the Visual Object and Space Perception battery) scores were correlated with raclopride C11 binding. Results: Bradykinesia (a summation of five items of the UHDRS motor scale) was the best predictor for stage, that is, functional capacity, and showed a highly significant relationship with putaminous D-2 binding (r = -0.94) and with CAG expansion length x years of age (r = 0.96). The exclusion of two patients with a rigid-akinetic HD variant did not alter these coefficients. Chorea was less well correlated than bradykinesia with D-2 binding in all striatal regions. Performance on different cognitive tests, especially in timed tasks, was highly correlated with raclopride C11 binding in caudate nucleus and ventral striatum. Conclusion: Loss of D-2 binding in the striatum is highly correlated with the deficit in fast motor and cognitive processing in patients with early Huntington's Disease. Thus, impairment of rapid execution of adequate responses to environmental changes seems to be a common manifestation of striatal disorders.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 49 条
[1]
STRIATAL AND NIGRAL NEURON SUBPOPULATIONS IN RIGID HUNTINGTONS-DISEASE - IMPLICATIONS FOR THE FUNCTIONAL-ANATOMY OF CHOREA AND RIGIDITY-AKINESIA [J].
ALBIN, RL ;
REINER, A ;
ANDERSON, KD ;
PENNEY, JB ;
YOUNG, AB .
ANNALS OF NEUROLOGY, 1990, 27 (04) :357-365
[2]
[Anonymous], 1968, Learn Disord, DOI DOI 10.1080/13803390591004428
[3]
[11C]raclopride-PET studies of the Huntington's disease rate of progression:: Relevance of the trinucleotide repeat length [J].
Antonini, A ;
Leenders, KL ;
Eidelberg, D .
ANNALS OF NEUROLOGY, 1998, 43 (02) :253-255
[4]
Striatal glucose metabolism and dopamine D-2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease [J].
Antonini, A ;
Leenders, KL ;
Spiegel, R ;
Meier, D ;
Vontobel, P ;
WeigellWeber, M ;
SanchezPernaute, R ;
deYebenez, JG ;
Boesiger, P ;
Weindl, A ;
Maguire, RP .
BRAIN, 1996, 119 :2085-2095
[5]
EFFECT OF AGE ON D(2)-DOPAMINE RECEPTORS IN NORMAL HUMAN BRAIN MEASURED BY POSITRON EMISSION TOMOGRAPHY AND C-11 RACLOPRIDE [J].
ANTONINI, A ;
LEENDERS, KL ;
REIST, H ;
THOMANN, R ;
BEER, HF ;
LOCHER, J .
ARCHIVES OF NEUROLOGY, 1993, 50 (05) :474-480
[6]
Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes [J].
Bäckman, L ;
Robins-Wahlin, TB ;
Lundin, A ;
Ginovart, N ;
Farde, L .
BRAIN, 1997, 120 :2207-2217
[7]
Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length [J].
Becher, MW ;
Kotzuk, JA ;
Sharp, AH ;
Davies, SW ;
Bates, GP ;
Price, DL ;
Ross, CA .
NEUROBIOLOGY OF DISEASE, 1998, 4 (06) :387-397
[8]
BENITEZ J, 1994, HUM GENET, V94, P563
[9]
Benton A. L., 1978, MULTILINGUAL APHASIA
[10]
THE NEUROPSYCHOLOGY OF HUNTINGTONS-DISEASE [J].
BRANDT, J ;
BUTTERS, N .
TRENDS IN NEUROSCIENCES, 1986, 9 (03) :118-120